ロード中...
The Role of Autologous Stem Cell Transplantation in the Treatment of Diffuse Large B-cell Lymphoma in the Era of CAR-T Cell Therapy
For many years now and based on the results of the PARMA trial, relapsed Diffuse Large B-cell Lymphoma (DLBCL) is treated with salvage combination cytotoxic chemotherapy (most often platinum-based) followed by high dose myeloablative chemotherapy and autologous stem cell transplantation (auto-HCT)....
保存先:
| 出版年: | Hemasphere |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Wolters Kluwer Health
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6924546/ https://ncbi.nlm.nih.gov/pubmed/31976472 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/HS9.0000000000000295 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|